UCLA and Parker Institute Continue Collaboration to Advance Next-Generation Cancer Immunotherapies

The collaboration is backed by a substantial new investment from PICI, which recently committed $125 million(Link is external) (Link opens in new window) to expand research efforts across a collaborative consortium of immuno-oncology academic research institutions. 

Read More